ACE and atrial fibrillation: Additional adjustment for age, gender, history of atrial fibrillation, New York Heart Association functional class, creatinine > 1.2 mg/dL, end-systolic global longitudinal strain and angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker use yielded a hazard ratio of 1.54 (95% confidence interval, 1.01–2.35, p = 0.046).